Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection.
CD4+ CD25+ regulatory T cells have been shown to maintain peripheral tolerance against self and foreign antigens. In this study we analyzed the effect of circulating CD4+ CD25+ T cells on CD8+-T-cell responses of patients with chronic and resolved hepatitis B virus (HBV) infection. We demonstrated that circulating CD4+ CD25+ T cells modulate the function and expansion of HBV-specific CD8+ cells ex vivo in all patients, regardless of whether they have chronic or resolved HBV infection. The possible role of CD4+ CD25+ T cells in the pathogenesis of chronic HBV infection is not supported by these data. However, these results might have implications for optimizing future immunotherapeutic approaches to HBV treatment.
Franzese
Ornella
O
Institute of Hepatology, University College London, 69-75 Chenies Mews, London WC1E 6HX, United Kingdom. a.bertoletti@ucl.ac.uk.
Kennedy
Patrick T F
PT
Gehring
Adam J
AJ
Gotto
Jim
J
Williams
Roger
R
Maini
Mala K
MK
Bertoletti
Antonio
A
D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D049109:Cell Proliferation; D002478:Cells, Cultured; D004279:DNA, Viral / Q000097:blood; D006510:Hepatitis B Antibodies / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000276:immunology / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000276:immunology*; D006801:Humans; D008875:Middle Aged; D015375:Receptors, Interleukin-2 / Q000032:analysis / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology*
D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006513:Hepatitis B e Antigens; D015375:Receptors, Interleukin-2
J Exp Med. 2000 Apr 17;191(8):1269-80
10770795
Nat Rev Immunol. 2003 Mar;3(3):253-7
12658273
J Exp Med. 2003 Sep 15;198(6):889-901
12975455
Eur J Immunol. 2003 Dec;33(12):3473-83
14635058
Hepatology. 2003 Dec;38(6):1437-48
14647055
J Virol. 2004 Mar;78(5):2454-9
14963140
Clin Exp Immunol. 2004 Mar;135(3):462-6
15008979
Immunity. 2004 Mar;20(3):293-303
15030773
Semin Immunol. 2004 Apr;16(2):89-98
15036232
J Clin Invest. 2004 Apr;113(7):963-72
15057302
J Virol. 2004 Jun;78(11):5707-19
15140968
J Immunol. 1990 Nov 15;145(10):3442-9
2230128
J Immunol. 1995 Aug 1;155(3):1151-64
7636184
J Exp Med. 1996 Aug 1;184(2):387-96
8760792
Eur J Immunol. 1996 Aug;26(8):1683-9
8765006
Cell. 2000 May 26;101(5):455-8
10850488
J Clin Invest. 1997 Apr 1;99(7):1472-7
9119989
Curr Opin Immunol. 2000 Aug;12(4):403-8
10899021
Hepatology. 2001 Apr;33(4):963-71
11283861
J Immunol. 2001 Aug 1;167(3):1137-40
11466326
J Immunol. 2001 Aug 1;167(3):1245-53
11466340
Nat Immunol. 2001 Sep;2(9):816-22
11526392
Hepatology. 2001 Dec;34(6):1225-41
11732013
J Infect Dis. 2002 Mar 15;185(6):720-7
11920289
Nature. 2002 Dec 5;420(6915):502-7
12466842
J Virol. 2003 Jan;77(1):68-76
12477811
J Infect Dis. 2003 Feb 15;187(4):679-82
12599086
J Exp Med. 2003 Jul 21;198(2):249-58
12874258